Search Results 251-260 of 1349 for ai免费网站绘画,网络ai培训,ai写作网站源码,ai智能体网站,ai对话聊天网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer - Mayo Clinic

    A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer · Overview · Participation eligibility.

  2. Implementation of Meaning-Centered Psychotherapy for Veterans with Advanced Cancer - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of MCP on depression, psychosocial distress, and QOL in veterans with advanced cancer. This study ...

  3. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.

  4. Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    About this study. The purpose of this study is to determine the efficacy and safety of investigational medical products (MEDI4736 monotherapy, tremelimumab ...

  5. Plasma Endocannabinoid Levels in Patients with Ischemic Cerebrovascular Disease - Mayo Clinic

    The purpose of this observational study is to describe how the human endocannabinoid system (ECS) responds to an ischemic stroke or transient ischemic attack ...

  6. Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma - Mayo Clinic

    About this study. This is a Phase Ib, open-label, multicenter, global study designed to assess the safety and tolerability of RO6870810 as monotherapy and ...

  7. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

    Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...

  8. Stewardship, AMR Technology, and Ethics - Mayo Clinic

    About this study. The purpose of this study is to explore ethical, legal, and social implications (ELSI) of stakeholder attitudes toward new genomic ...

  9. Anne Gingery, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic's Anne Gingery, Ph.D., focuses on studying the impacts of aging, cellular senescence, immune dysregulation and metabolic dysfunction in ...

  10. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

    Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.